Is the History Repeated? Can (2R,6R)-Hydroxynorketamine be Another Antidepressant?

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Historically, active metabolites have driven psychiatric drug discovery, leading to medications like desipramine and paliperidone.
• Ketamine is a significant breakthrough in depression research, undergoing rapid metabolism into various compounds.
• Identifying active metabolites of ketamine is crucial for understanding its mechanisms and developing new antidepressants.

Purpose of the Study:

• To investigate the role of (2R,6R)-hydroxynorketamine (HNK), a metabolite of (R,S)-ketamine, in antidepressant effects.
• To determine if HNK is essential for the antidepressant activity of ketamine.
• To explore the potential of HNK as a basis for novel antidepressant medications.

Main Methods:

• Administration of (R,S)-ketamine and its metabolite (2R,6R)-HNK.
• Comparative analysis of the antidepressant potency of ketamine and HNK.
• Assessment of the necessity of HNK for ketamine's antidepressant effects.

Main Results:

• The antidepressant effect of (2R,6R)-HNK was found to be less potent than that of (R)-ketamine and (R,S)-ketamine.
• (2R,6R)-HNK was not essential for the antidepressant effects of (R)-ketamine.
• Despite limitations, HNK warrants further investigation for antidepressant potential.

Conclusions:

• While (2R,6R)-HNK is not as potent as ketamine, it holds potential for future antidepressant drug discovery.
• Further rigorous research on (2R,6R)-HNK is necessary to develop safer and more effective antidepressants.
• The study highlights the complex role of ketamine metabolites in antidepressant action.